Dr. Patterson said he doesn’t know what kind of care the placebo (M/M) patients are getting, so he can’t really know what results we’ll get. So hopefully the interim results will show significance because a lot of people would have died early on, but the end results won’t, since the placebo arm is now getting much better care and people don’t die as much, like Rockleo said. I’m just saying I don’t see why some say the M/M trial was a mistake when we may have a better chance there, with a more reasonable endpoint than the S/C one.
Market Data 
Markets 
